Dr Stephanie Baldeweg

Dr Stephanie Baldeweg  Tel: 020 3447 9373
Fax: 020 3447 9201
Email: stephanie.baldeweg@uclh.nhs.uk

Location:
University College Hospital; National Hospital for Neurology and Neurosurgery

Specialities:
Long-term-follow-up (LTFU): Late effects of Cancer, Diabetes, Endocrinology, Brain Tumour Service (Neuro-Oncology)

Professional background

Dr Stephanie Baldeweg is a Consultant Physician in Diabetes and Endocrinology at University College London Hospital and Honorary Senior Lecturer in the Department of Medicine at UCL. She graduated from Humboldt University, Berlin in 1990 and undertook her Specialist Training in London. She was awarded the MD for the thesis on “Insulin resistance and endothelial function in health and type 2 diabetes”. Dr Baldeweg is the Training Program Director for the North Thames Rotation in Diabetes and Endocrinology. She regularly lectures at national and international meetings as well as Patient days for Support groups such as Diabetes UK and the Pituitary Foundation. She was made a Fellow of the Royal College of Physicians of Ireland in March 2009 (FRCPI) and a Fellow of the Royal College of Physicians (London) in June 2009 (FRCP).

Research interests

Dr Baldeweg is interested in all aspects of diabetes and endocrinology. She has a special clinical and research interest in pituitary disease.

Her other interests include diabetes, thyroid and reproductive as well as osteoporosis, weight management and cardiovascular risk reduction.
She also has an interest in pregnancy preparation for women with diabetes and endocrine disease.

Publications

Rajasekaran S, Vanderpump M, Baldeweg SE et al (2011) UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf). 2011 Jan;74(1):9-20. doi: 10.1111/j.1365-2265.2010.03913

Igreja S, Chahal HS, King P et al  (2010) Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families. Hum Mutat. 2010 Aug;31(8):950-60.

Mortagy I, Kielmann K, Baldeweg SE et al (2010) Integrating preconception care for women with diabetes into primary care: a qualitative study. Br J Gen Pract. 2010 Nov;60(580):815-21.

Theodoraki A, Baldeweg SE (2008) Gestational diabetes mellitus. Br J Hosp Med (Lond) Oct;69(10):562-7

Theodoraki A, Baldeweg SE (2008) Diabetic Ketoacidosis: diagnosis and management in adults Foundation Years Journal   Sept  2 (7): 309-312

Thorogood N, Baldeweg SE (2008) Pituitary disorders: an overview for the general physician. Br J Hosp Med (Lond). Apr;69(4):198-204.

Natali A, Toschi E, Baldeweg S, Ciociaro D, Favilla S, Sacca L, Ferrannini E. Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes Diabetes. 2006 Apr;55(4):1133-40.

Baldeweg SE, Pollock JR, Powell M, Ahlquist J. A spectrum of behaviour in silent corticotroph pituitary adenomas. British Journal of Neurosurgery. 2005,  Volume 19, Number 1, February 2005, pp. 38-42(5)

Natali A, Toschi E, Baldeweg S, Casolaro A, Baldi S, Sironi AM, Yudkin JS, Ferrannini E. Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J. 2005 Mar;26(5):464-71. Epub 2005 Feb 3.

Baldeweg SE, Hurel SJ. Aspirin use for prevention of vascular complications in diabetes. Pract Diab Int , 316-317, Sept 2004 

Natali A, Baldeweg S, Toschi E, Capaldo B, Barbaro D, Gastaldelli A, Yudkin JS, Ferrannini E. Vascular effects of improving metabolic control with metformin or rosiglitazone in type 2 diabetes. Diabetes Care. 2004 Jun;27(6):1349-57.

DG. Morris, B Kola, N Borboli, GA Kaltsas, M Gueorguiev, TH Jones, SE Baldeweg, M Powell, M Korbonits, AB Grossman. Identification of adrenocorticotropin receptor messenger ribonucleic Acid in the human pituitary and its loss of expression in pituitary adenomas Clin Endocrinol Metab 2003 Dec; 88 (12):6080-7

Powell M, Pollock JR, Baldeweg SE, Lightman SL (2003) Early postoperative anagement of pituitary tumors: in Management of Pituitary Tumors, Ed. Powell M, Lightman SL, Laws ER, Sec Edition, Humana Press, 173-180

Blackwell VC, Salis D, Groves RW, Baldeweg SE, Conway GS, Unwin RJ. Partial lipodystrophy, polycystic ovary syndrome and proteinuria: a common link to insulin resistance? J R Soc Med 2001; 94: 238-240.

Baldeweg SE, Golay A, Natali A, Balkau B, Del Prato S, Coppack SW. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. Eur J Clin Invest 2000; 30: 45-52.

Baldeweg SE, Pink AM, Yudkin JS, Coppack SW. The relationship between obesity, vascular reactivity and endothelial dysfunction in subjects with non-insulin dependent diabetes mellitus. Int J Obes.Relat Metab Disord. 2000; 24 Suppl 2: S134-S135.

GMC/GDC number: 4052111 

 Useful links